Molecular Partners AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2024 | 443,221 | $2.14 M | 0.00% | 1.34% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 400,000 | $2.03 M | 0.00% | 1.21% |
| UBS GROUP AG | 11/14/2024 | 5,246 | $26,686 | 51.57% | 0.02% |
| MORGAN STANLEY | 11/14/2024 | 500 | $2,544 | 36.24% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 269 | $1,296 | 0.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| OLD MISSION CAPITAL LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Molecular Partners AGinstitutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of Molecular Partners AG. The most heavily invested institutionals were:
BVF INC/IL: 443,221
SUVRETTA CAPITAL MANAGEMENT, LLC: 400,000
UBS Group AG: 5,246
MORGAN STANLEY: 500
RHUMBLINE ADVISERS: 269
TANG CAPITAL MANAGEMENT LLC: 0
2.56% of Molecular Partners AG stock is owned by institutional investors.
Institutional investors have bought a total of 849,236 shares in the last 24 months. This purchase volume represents approximately $4.51 M in transactions.